Newer Targets |

Palleon Pharmaceuticals to Present Preclinical Data on EAGLE-Her2 and Anti-Siglec-9 Antibody Programs at the...

Firstwordpharma News - November 19, 2019

Palleon Pharmaceuticals to Present Preclinical Data on EAGLE-Her2 and Anti-Siglec-9 Antibody Programs at the 11th Annual Protein & Antibody Engineering Summit

Codiak Presents First Preclinical Data for exoASO, Engineered Exosomes Designed to Reprogram Tumor-Associated Macrophages

Firstwordpharma News - November 18, 2019

0

Codiak Presents First Preclinical Data for exoASO, Engineered Exosomes Designed to Reprogram Tumor-Associated Macrophages

Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program

Firstwordpharma News - November 18, 2019

0

Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program

Researchers identify potential nanotechnology therapy for rare, incurable bone cancer

Firstwordpharma News - November 7, 2019

0

Researchers identify potential nanotechnology therapy for rare, incurable bone cancer

DCprime Presents Comprehensive Preclinical Results Supporting Lead Clinical Candidate DCP-001

Firstwordpharma News - November 6, 2019

0

DCprime Presents Comprehensive Preclinical Results Supporting Lead Clinical Candidate DCP-001

Novel discovery in gene therapy to treat kidney diseases …

Stanford researchers program cancer-fighting cells to resist exhaustion, attack solid tumors…

Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach…

Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…

FDA Committee Votes 6-6 on Durect’s Non-Opioid Pain Drug

Novo Nordisk’s Ozempic Wins Approval for Reducing Cardiovascular Events in Diabetes…

FDA advisory panel split on whether to approve Durect’s Posimir for…

Breast cancer patients to have further NICE-approved drug combination option on…

Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for…

TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy…

US judge hacks $8-billion damages verdict against Johnson & Johnson in…

JPM Day 3: High Prices in San Francisco Are a Problem,…

Newer Targets

Novel discovery in gene therapy to treat kidney diseases ...

Stanford researchers program cancer-fighting cells to resist exhaustion, attack solid tumors in mice

Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach to Create New AAV Capsids for Gene Therapies

Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver Disease

Palleon Pharmaceuticals to Present Preclinical Data on EAGLE-Her2 and Anti-Siglec-9 Antibody Programs at the...

Codiak Presents First Preclinical Data for exoASO, Engineered Exosomes Designed to Reprogram Tumor-Associated Macrophages

Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program

Researchers identify potential nanotechnology therapy for rare, incurable bone cancer

DCprime Presents Comprehensive Preclinical Results Supporting Lead Clinical Candidate DCP-001

LATEST NEWS

PureTech Health Affiliates Gelesis and Vedanta Biosciences Announce Presentations at Digestive Disease Week

Clene Nanomedicine Announces First Patient Dosed in the REPAIR-MS Clinical Trial for the Treatment of Multiple Sclerosis with Lead Nanocatalytic Therapeutic, CNM-Au8

Taro Provides Results for the Year Ended March 31, 2019

MUST READ

Poxel Announces Updates to its Management Team

GenSight Biologics Announces Presentation of 72-Week Data from the REVERSE & RESCUE Phase III...

Vaccibody AS to present data on VB10.NEO and VB10.16 at upcoming American Association for...

POPULAR POSTS

United BioPharma Receives US FDA Approval for UB-621 Phase 2 Trial...

Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial...

Ocular Therapeutix Announces FDA Approval of Supplemental New Drug Application (sNDA)...

POPULAR CATEGORY